Dr. Yong presents on unusual clinical presentations of endometriosis, as well as unusual locations and histological changes of endometriosis. Paul Yong, MD, PhD, FRCSC is a gynaecologist with fellowship training in advanced laparoscopic surgery, and a researcher in endometriosis located in Vancouver, Canada.
Bleeding in early pregnancy is strongly associated with pregnancy loss. Progesterone is essential for the maintenance of pregnancy. Several small trials have suggested that progesterone therapy may improve pregnancy outcomes in women who have bleeding in early pregnancy. A multicenter, randomized, double-blind, placebo-controlled trial to evaluate progesterone, as compared with placebo, in women with vaginal bleeding in early pregnancy.
Dr. Yeung discusses the pre-and post surgery management of endometriosis, with a look at adhesion prevention, the use of Gore-Tex (surgical anti-adhesion membrane) in decreasing the formation of adhesions. Dr. Yeung is interested in research on pain, quality of life, and fertility following laser excision surgery for endometriosis. Other research interests include developing a non-invasive diagnostic test for early-stage endometriosis. He performs scarless laparo-endoscopic single-site (LESS) surgery, which is a minimally invasive single-incision procedure. He also specializes in laser excision of endometriosis and restorative surgery.
Learn how endometriosis, in both an operative and population cohort, is associated with pregnancy complications (including early pregnancy loss, ectopic pregnancies, hypertensive disorders of pregnancy, gestational diabetes, small-for-gestational age, and preterm birth). The ENDO Study is a collaborative epidemiologic study whose goal is to assess the relation between exposure to environmental chemicals and lifestyle factors that may affect womens reproductive health. Particular focus will be on the relation between hormonally active chemicals and risk of developing endometriosis considering womens lifestyles.
This webinar reviews the use and application of an at home urinary test that measures the presence of progesterone in urine (or more specifically tests a urine metabolite of progesterone, pregnanediol 3-glucuronide (PdG), and how this can be used alongside Fertility awareness based methods and may aid some users in increasing the efficacy of Fertility Awareness Based Methods. Dr. Martin Owen is a fellow of the Reproductive Health Research Institute (RHRI) and founded Vitae Medical Solutions to address the need for clinical and technological solutions in the Restorative Reproductive Medicine field internationally.
Recordings from IIRRM’s AGM and International Conference for RRM held in Dublin and Restorative Reproduction hosted by NeoFertility are now available for purchase. Updates in progesterone, DHEA and the Oestradiol curve, immunological aspects of infertility and reproductive health, treatment of silent endometriosis, an overview of the new Neo app and case studies as well as some surprising discoveries! Fill out the online evaluations for each day to receive up to 12 CME/CPD are available until Sept 27, 2019.
There is no excerpt because this is a protected post.
Presented by Joseph Stanford, MD, MSPH. Review the concepts of pregnancy rates, effectiveness, perfect use, typical use, achieving-related behavior, and avoiding-related behavior, in relation to natural family planning, fertility awareness, and fertility appreciation methods. Discuss statistical methods for effectiveness studies and examine strengths and weaknesses of existing studies.
First Name * Last Name * Titles & Degrees Headshot This will be used in promoting the webinar. Please enter your CV or a short […]